Related Experiment Video
Updated: Jul 26, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
[Translated article] Immunotherapy and Targeted Therapy in Patients With Advanced Melanoma and the V600 BRAF
D Moreno-Ramírez1, A Fernández-Orland1, L Ferrándiz1
1Unidad de Melanoma, Servicio de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Virgen Macarena, Seville, Spain.
Systemic treatments like immunotherapy and targeted therapy improve survival for advanced melanoma. An algorithm helps guide treatment decisions for BRAF-mutated melanoma, balancing efficacy and toxicity.
Area of Science:
- Oncology
- Dermatology
- Medical Research
Background:
- Advanced melanoma treatment has evolved with immunotherapy and targeted therapy.
- BRAF mutations are present in 50% of melanoma patients, influencing treatment selection.
- Optimal sequencing of systemic therapies requires consideration of drug, tumor, and patient factors.
Approach:
- Literature review on immunotherapy and targeted therapy in melanoma.
- Development of a decision-making algorithm for first-line treatment.
- Analysis of survival outcomes, drug efficacy, and toxicity profiles.
Key Points:
- Immunotherapy (ipilimumab/nivolumab) offers best survival but high toxicity.
- Targeted therapy presents a favorable option in specific clinical scenarios.
- BRAF mutation status is critical for selecting advanced melanoma treatments.
Conclusions:
- A structured approach is needed to optimize systemic therapy sequencing.
- The presented algorithm aids clinicians in choosing between immunotherapy and targeted therapy.
- Personalized treatment strategies are essential for improving outcomes in advanced melanoma.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...